Cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female patients aged 40–80 years. 2.Patients who have been pathologically and histologically diagnosed with cervical cancer at Stage ?A–?A, meet the indications for radical hysterectomy, and are scheduled to undergo sentinel lymph node biopsy and radical hysterectomy via vNOTES. 3.Patients classified as ASA Physical Status Class ?–? according to the American Society of Anesthesiologists (ASA) Physical Status Classification System. 4.Patients who are able to cooperate with the follow-up visits and related examinations specified in the protocol. 5.Patients and their family members have a full understanding of the purpose, procedures and risks of this study, and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.A history of severe pelvic and abdominal adhesions that may interfere with surgical procedures. 2.Complicated with other malignant tumors. 3.Patients who are positive for human immunodeficiency virus (HIV) antibody; positive for hepatitis C virus (HCV) antibody; positive for Treponema pallidum antibody and judged by the investigators to have a relatively high risk of transmission. 4.Patients with severe systemic diseases who are deemed unfit for surgical treatment by the investigators. 5.Hypersensitivity to fluorescent tracers (e.g., indocyanine green). 6.Patients with mental illnesses who are unable to cooperate with the study. 7.Other circumstances that the investigators consider inappropriate for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fluorescent tracing effect;Surgical success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Recovery Indicators;Tumor Recurrence Status;Postoperative Quality of Life; | — |
Countries
China
Contacts
Chengdu Women's and Children's Central Hospital